|
Market Cap | 1.24M | EPS (ttm) | -11.07 |
P/E | - | EPS this Y | 69.48% |
Forward P/E | - | EPS next Y | 64.00% |
PEG | - | EPS past 5Y | -10.72% |
P/S | - | EPS next 5Y | - |
P/B | 1.70 | EPS Q/Q | 53.11% |
Dividend | - | Sales Q/Q | - |
Insider Own | 10.01% | Inst Own | 5.34% |
Insider Trans | 0.00% | Inst Trans | 12.13% |
Short Float | 3.77% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 25.00 |
Avg Volume | 3.23M | 52W Range | 1.20 - 38.50 |
|
|
|
Auddia, Inc. engages in the development of audio content ecosystem technology and products. The firm operates an interactive radio platform called Auddia, which is a subscription based commercial free AM and FM software application. It also offers Vodacast, an interactive podcasting platform and application, which enables listeners to see video and other digital content in a digital feed that correlates with the podcast audio. The company was founded by Jeffrey J. Thramann in 2011 and is headquartered in Boulder, CO. |
|
|
|
Market Cap | 118.35M | EPS (ttm) | -1.13 |
P/E | - | EPS this Y | -16.43% |
Forward P/E | - | EPS next Y | 30.67% |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 4.65 | EPS Q/Q | -93.07% |
Dividend | - | Sales Q/Q | - |
Insider Own | 30.74% | Inst Own | 12.46% |
Insider Trans | 0.00% | Inst Trans | 25.35% |
Short Float | 8.81% | Earnings | Apr 29/a |
Analyst Recom | 2.33 | Target Price | 4.99 |
Avg Volume | 189.58K | 52W Range | 1.03 - 4.60 |
|
|
Today | Initiated |
Maxim Group |
Buy |
$4 |
|
|
5E Advanced Materials, Inc. is an exploration stage company, which engages in the provision of boron and lithium properties in Australia and the United States. It focuses on supplying boron specialty materials, complemented by lithium co-product production. The company was founded on September 23, 2021, and is headquartered in Hesperia, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Fairchild George | Principal Accounting Officer | Sep 01 '23 | Option Exercise | 0.00 | 1,225 | 0 | 1,225 | Sep 06 04:27 PM | SALISBURY DAVID J | Director | Jun 09 '23 | Buy | 3.96 | 4,955 | 19,617 | 7,286 | Jun 12 05:55 PM | vant Hoff Graham | Director | Jun 07 '23 | Buy | 3.85 | 4,250 | 16,384 | 4,250 | Jun 07 04:05 PM |
|
|
|
|
Market Cap | 125.68M | EPS (ttm) | -0.54 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 25.94% |
P/S | 71.82 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 52.99% |
Dividend | - | Sales Q/Q | 87.78% |
Insider Own | 39.17% | Inst Own | 2.38% |
Insider Trans | 0.00% | Inst Trans | -20.45% |
Short Float | 9.99% | Earnings | - |
Analyst Recom | 2.00 | Target Price | 1.25 |
Avg Volume | 211.53K | 52W Range | 0.65 - 4.00 |
|
|
|
BeyondSpring, Inc. engages in the development and commercialization of immuno-oncology cancer therapies. It operates through the Plinabulin Pipeline and TPD Platform segments. The Plinabulin Pipeline segment focuses on the development of cancer therapies. The TPD Platform segment engages in the development of therapeutic agents and discover chemical entities. The company was founded by Lan Huang and Lin Qing Jia in 2010 and is headquartered in Florham Park, NJ. |
|
| |
|
Market Cap | 3.75M | EPS (ttm) | - |
P/E | - | EPS this Y | 73.66% |
Forward P/E | - | EPS next Y | 29.05% |
PEG | - | EPS past 5Y | 50.52% |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | 87.98% |
Dividend | - | Sales Q/Q | - |
Insider Own | 0.89% | Inst Own | 0.07% |
Insider Trans | 0.00% | Inst Trans | 19.08% |
Short Float | 6.54% | Earnings | Apr 10/b |
Analyst Recom | 1.00 | Target Price | 287.34 |
Avg Volume | 1.18M | 52W Range | 1.35 - 23.60 |
|
|
|
Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through the Switzerland and Australia geographical segments. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda. |
|
|
|
Market Cap | 48.01M | EPS (ttm) | -0.17 |
P/E | - | EPS this Y | 75.19% |
Forward P/E | 161.00 | EPS next Y | 110.00% |
PEG | - | EPS past 5Y | - |
P/S | 0.53 | EPS next 5Y | - |
P/B | 2.53 | EPS Q/Q | 166.21% |
Dividend | - | Sales Q/Q | 15.24% |
Insider Own | 63.37% | Inst Own | 2.82% |
Insider Trans | 0.11% | Inst Trans | -31.46% |
Short Float | 0.41% | Earnings | May 14/a |
Analyst Recom | 1.00 | Target Price | 1.25 |
Avg Volume | 433.64K | 52W Range | 0.40 - 3.48 |
|
|
|
iPower, Inc. engages in the online retail and supply of consumer home, garden, in-home farming, pet, and wellbeing products. It sells its brands such as Simple Deluxe, YSSOA, Zenhydro, Flourish, iPOWER, iFarm, FluffyDream, ScratchMe, and HealSmart through zenhydro.com, simpledeluxe.com, and various third-party online platforms. The company offers grow light systems, advanced heating, ventilation and air conditioning (HVAC) systems, water pumps, heaters, chillers and filters, nutrient and fertilizer delivery systems, and various growing media typically made from soil, rock wool or coconut fiber. It also provides home goods supplies including commercial fans, floor and wall fans, storage and shelving units, and chairs. The company was founded by Chenlong Tan and Allan Huang on April 11, 2018 and is headquartered in Rancho Cucamonga, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
TAN CHENLONG | Chief Executive Officer | May 21 '24 | Buy | 1.54 | 20,000 | 30,900 | 8,063,334 | May 21 08:57 PM | Vassily Kevin | Chief Financial Officer | Jun 02 '23 | Buy | 0.68 | 5,000 | 3,400 | 22,000 | Jun 02 04:54 PM | TAN CHENLONG | Chief Executive Officer | Jun 01 '23 | Buy | 0.68 | 10,000 | 6,790 | 8,043,334 | Jun 02 04:20 PM | Vassily Kevin | Chief Financial Officer | Jun 01 '23 | Buy | 0.68 | 5,000 | 3,395 | 17,000 | Jun 02 04:54 PM | TAN CHENLONG | Chief Executive Officer | May 31 '23 | Buy | 0.66 | 10,000 | 6,560 | 8,033,334 | Jun 02 04:20 PM |
|
|
| |
|
Market Cap | 3.17B | EPS (ttm) | - |
P/E | - | EPS this Y | 103.14% |
Forward P/E | 64.00 | EPS next Y | 206.59% |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 66.32% | Inst Own | 29.70% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 4.64% | Earnings | May 22/a |
Analyst Recom | 2.14 | Target Price | 27.36 |
Avg Volume | 847.05K | 52W Range | 18.71 - 26.41 |
|
|
|
BBB Foods, Inc. engages in the provision of a limited assortment of products that cover the daily grocery needs. It offers the grocery hard discount model where products offered are generally value for money. The company was founded by K. Anthony Hatoum on July 9, 2004 and is headquartered in Mexico City. |
|
|
|
Market Cap | 1.67B | EPS (ttm) | 0.07 |
P/E | 93.31 | EPS this Y | 639.68% |
Forward P/E | 7.27 | EPS next Y | 36.97% |
PEG | - | EPS past 5Y | - |
P/S | 2.17 | EPS next 5Y | - |
P/B | 1.70 | EPS Q/Q | 205.48% |
Dividend | 3.27% | Sales Q/Q | 48.45% |
Insider Own | 10.00% | Inst Own | 75.17% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 3.87% | Earnings | May 23/b |
Analyst Recom | 1.44 | Target Price | 8.06 |
Avg Volume | 2.18M | 52W Range | 5.19 - 8.87 |
|
|
|
Borr Drilling Ltd. engages in the provision of offshore drilling services to the oil and gas industry. It operates through Dayrate; and Integrated Well Services (IWS) segments. The Dayrate segment consists of rig charters and ancillary services. The IWS segment provides integrated well services through Opex and Akal. The company was founded by Tor Olav Troim on August 8, 2016 and is headquartered in Hamilton, Bermuda. |
|
| |
|
Market Cap | 69.98M | EPS (ttm) | 0.08 |
P/E | 50.62 | EPS this Y | -33.30% |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 9.09 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 22.20% |
Dividend | - | Sales Q/Q | 42.90% |
Insider Own | 82.29% | Inst Own | - |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | - | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 780.44K | 52W Range | 3.21 - 6.04 |
|
|
|
Raytech Holdings Company Limited, through its subsidiary, manufactures electronic personal care and household appliances in Hong Kong. It offers hair care products, such as hair dryers, hair straighteners, and curling iron products; trimmer series, including facial shavers, nose trimmers, and eyebrow trimmers; eyelash curlers; neck care series; nail care series; tooling products; and other personal care appliance series, such as body and facial brushes, reset brushes, callus removers, sonic peeling products, handy fans, and others. It also provides product design and development services. The company was founded in 1993 and is based in Kowloon Bay, Hong Kong with additional location in Zhongshan, China. |
|
|
|
Market Cap | 88.71M | EPS (ttm) | -13.72 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -12.67% |
P/S | 633.64 | EPS next 5Y | - |
P/B | 2.08 | EPS Q/Q | -27.85% |
Dividend | - | Sales Q/Q | 600.00% |
Insider Own | 86.04% | Inst Own | 1.37% |
Insider Trans | 0.00% | Inst Trans | -3.08% |
Short Float | 0.35% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 9.40K | 52W Range | 7.86 - 35.17 |
|
|
|
Serina Therapeutics, Inc. operates as a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley on March 26, 2024 and is headquartered in Huntsville, AL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Bailey Gregory | Director | May 20 '24 | Buy | 9.00 | 100 | 900 | 100 | May 22 04:15 PM |
|
|
|
|
Market Cap | 188.02M | EPS (ttm) | -0.65 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 62.33 | EPS Q/Q | -1281.60% |
Dividend | - | Sales Q/Q | - |
Insider Own | 42.48% | Inst Own | 0.27% |
Insider Trans | 1.11% | Inst Trans | - |
Short Float | 0.18% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 44.87K | 52W Range | 4.76 - 20.72 |
|
|
|
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company, which focuses on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. The firm's initial focus on treatments to inhibit the production of pro-inflammatory cytokines, such as IL-17, by oral administration of TELOMIR-1 as a therapeutic treatment for stem cells in situ. TELOMIR-1 is under investigation to provide a potential therapeutic intervention against age-related inflammatory conditions such as hemochromatosis, as well as for post-chemotherapy recovery, by interrupting and preventing the IL-17 induced inflammatory pathways that create the systemic imbalance of cellular metals. The company was founded by Christopher C. Chapman Jr. on August 26, 2021 and is headquartered in Baltimore, MD. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Bay Shore Trust | 10% Owner | Feb 13 '24 | Buy | 7.00 | 138,000 | 966,000 | 5,455,431 | Feb 15 04:11 PM |
|
|
|